Results 1 to 10 of about 710 (108)

Cardiac extracellular volume fraction in cats with preclinical hypertrophic cardiomyopathy [PDF]

Journal of Veterinary Internal Medicine, 2021
Background Cardiac magnetic resonance imaging (CMR) allows for detection of fibrosis in hypertrophic cardiomyopathy (HCM) by quantification of the extracellular volume fraction (ECV).
Ryan C. Fries, Saki Kadotani, Stephanie C. J. Keating, Jonathan P. Stack   +3 more
doaj   +3 more sources

Assessment of liver cirrhosis severity with extracellular volume fraction MRI

Scientific Reports, 2022
We aimed to investigate the diagnostic utility of MRI extracellular volume fraction (ECV) for the assessment of liver cirrhosis severity as defined by Child–Pugh class. In this retrospective study, 90 patients (68 cirrhotic patients and 22 controls), who
Narine Mesropyan, Patrick A. Kupczyk, Leona Dold, Michael Praktiknjo, Johannes Chang, Alexander Isaak, Christoph Endler, Dmitrij Kravchenko, Leon M. Bischoff, Alois M. Sprinkart, Claus C. Pieper, Daniel Kuetting, Christian Jansen, Ulrike I. Attenberger, Julian A. Luetkens   +14 more
doaj   +3 more sources

Myocardial T1 and extracellular volume fraction mapping at 3 tesla [PDF]

Journal of Cardiovascular Magnetic Resonance, 2011
Background To compare 11 heartbeat (HB) and 17 HB modified lock locker inversion recovery (MOLLI) pulse sequence at 3T and to establish preliminary reference values for myocardial T1 and the extracellular volume fraction (ECV).
Lee Jason J, Liu Songtao, Nacif Marcelo S, Ugander Martin, Han Jing, Kawel Nadine, Sibley Christopher T, Kellman Peter, Arai Andrew E, Bluemke David A   +9 more
doaj   +3 more sources

Prognostic Impact of Myocardial Extracellular Volume Fraction Assessment Using Dual‐Energy Computed Tomography in Patients Treated With Aortic Valve Replacement for Severe Aortic Stenosis

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Myocardial extracellular volume fraction (ECV), measured by cardiac magnetic resonance imaging, is a useful prognostic marker for patients who have undergone aortic valve replacement (AVR) for aortic stenosis.
Masataka Suzuki, Takayoshi Toba, Yu Izawa, Hiroshi Fujita, Keisuke Miwa, Yu Takahashi, Hiroyuki Toh, Hiroyuki Kawamori, Hiromasa Otake, Hidekazu Tanaka, Sei Fujiwara, Yoshiaki Watanabe, Atsushi K. Kono, Kenji Okada, Ken‐ichi Hirata   +14 more
doaj   +3 more sources

Triglyceride–Glucose Index and Extracellular Volume Fraction in Patients With Heart Failure [PDF]

Frontiers in Cardiovascular Medicine, 2021
Background: The triglyceride–glucose (TyG) index had been proposed as a reliable surrogate marker of insulin resistance. We aimed to evaluate the association between TyG index and myocardial fibrosis, which was quantified by extracellular volume (ECV ...
Shaomin Yang, Yongxing Du, Ziwei Liu, Rong Zhang, Xiaoxin Lin, Yufeng Ouyang, Haixiong Chen   +6 more
doaj   +3 more sources

Measurement of extracellular volume fraction using magnetic resonance-based conductivity tensor imaging

Frontiers in Physiology, 2023
Conductivity tensor imaging (CTI) using MRI is an advanced method that can non-invasively measure the electrical properties of living tissues. The contrast of CTI is based on underlying hypothesis about the proportionality between the mobility and ...
Bup Kyung Choi, Nitish Katoch, Ji Ae Park, Jin Woong Kim, Tong In Oh, Hyung Joong Kim, Eung Je Woo   +6 more
doaj   +1 more source

Myocardial extracellular volume quantification by computed tomography predicts outcomes in patients with severe aortic stenosis.

PLoS ONE, 2021
BackgroundThe extent of myocardial fibrosis in patients with severe aortic stenosis might have an important prognostic value. Non-invasive imaging to quantify myocardial fibrosis by measuring extracellular volume fraction might have an important clinical
Yoav Hammer, Yeela Talmor-Barkan, Aryeh Abelow, Katia Orvin, Yaron Aviv, Noam Bar, Amos Levi, Uri Landes, Gideon Shafir, Alon Barsheshet, Hana Vaknin-Assa, Alexander Sagie, Ran Kornowski, Ashraf Hamdan   +13 more
doaj   +1 more source

Cardiac computed tomography-derived extracellular volume fraction in late anthracycline-induced cardiotoxicity

International Journal of Cardiology: Heart & Vasculature, 2021
Cardiotoxicity in the late phase after anthracycline drugs administration remains to be defined. Of the 44 patients who received anthracycline treatment, 7 were found to have cancer therapeutics–related cardiac dysfunction (CTRCD).
Koichi Egashira, Daisuke Sueta, Mai Tomiguchi, Masafumi Kidoh, Seitaro Oda, Hiroki Usuku, Kaori Hidaka, Lisa Goto-Yamaguchi, Aiko Sueta, Takashi Komorita, Masafumi Takae, Fumi Oike, Koichiro Fujisue, Eiichiro Yamamoto, Shinsuke Hanatani, Seiji Takashio, Yuichiro Arima, Satoshi Araki, Koichi Kaikita, Kenichi Matsushita, Yutaka Yamamoto, Toshinori Hirai, Kenichi Tsujita   +22 more
doaj   +1 more source

Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background Spironolactone may have prognostic benefit in selected patients with heart failure with preserved ejection fraction. This study assessed the myocardial tissue effects of spironolactone in heart failure with preserved ejection fraction. Methods
Adam K. McDiarmid, Peter P. Swoboda, Bara Erhayiem, Katrina A. Bounford, Petra Bijsterveld, Keith Tyndall, Graham J. Fent, Pankaj Garg, Laura E. Dobson, Tarique A. Musa, James R. J. Foley, Klaus K. Witte, Mark T. Kearney, John P. Greenwood, Sven Plein   +14 more
doaj   +1 more source

Treatment Response Evaluation of Cardiac Amyloidosis Using Serial T1- and T2-Mapping Cardiovascular Magnetic Resonance Imaging

대한영상의학회지, 2021
Amyloidosis is a multisystemic disease characterized by the accumulation of abnormal proteins in extracellular spaces in various organs, with frequent involvement of the myocardium. We report a case of a patient who had cardiac amyloidosis with a trend
Jinwoo Son, Yoo Jin Hong
doaj   +1 more source